MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
Volume 4.70M
Average 0.95M
MMED Income Before Tax
Profit after all operating and non-operating items but before income tax.
MiniMed Group, Inc. Common StockNASDAQ: MMED
Income Before Tax · Q1 FY2026 · quarter ended Jul 2026
Income before tax of $4M in Q1 FY2026
Q1 FY2026 income before tax was $4M. Trailing-twelve-month income before tax was -$197M.
Context
- Income before tax amounted to 6.0% of revenue in FY2025, down 1.4 pp from a year earlier.
- Income before tax grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly income before tax holds near $4M or moves back toward the trailing-twelve-month quarterly average of -$49.25M.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Before Tax history
USD · from the income statement
- Latest · FY2025
- (187M) USD
- Year-over-year change
- +7.9%
| Period | Period end | Income Before Tax | YoY change |
|---|---|---|---|
| FY2025 | 2026-04-24 | (187M) | +7.9% |
| FY2024 | 2025-04-30 | (203M) | -190.0% |
| FY2023 | 2024-04-30 | (70M) | +7.9% |
| FY2022 | 2023-04-30 | (76M) | — |
Income Before Tax vs competitors
How MMED compares with its peers on the latest reported figures
- MMED's LTM Jul 2026 income before tax of -$197M is the lowest of the 7 companies compared; the peer median is $214.13M.
- Income before tax amounts to 6.1% of revenue for MMED, versus a peer median of 21.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $6.6B | +16.6% | +4.6% | 17.6% | |
| LTM Jun 2026 | $1.28B | +63.2% | +40.7% | 25.8% | |
| LTM Jun 2026 | $494.7M | +82.7% | +226.0% | 16.2% | |
| LTM Mar 2026 | -$66.44M | +6.4% | — | 60.3% | |
| LTM Mar 2026 | -$87.19M | -17.8% | — | 214.2% | |
| LTM Mar 2026 | -$98.06M | +43.8% | — | 9.5% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | -$197M | — | — | 6.1% |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding MMED) | $214.13M | +30.2% | +40.7% | 21.7% | |
Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 | FY2025 Apr 2026 |
|---|---|---|---|---|
| Revenue | 2.25B | 2.47B | 2.72B | 3.1B |
| Cost of Revenue | 937M | 1.03B | 1.19B | 1.42B |
| Gross Profit | 1.31B | 1.44B | 1.53B | 1.68B |
| Gross Margin | 58.3% | 58.2% | 56.2% | 54.2% |
| Research & Development | 429M | 437M | 438M | 448M |
| Selling, General & Admin | 960M | 1.06B | 1.13B | 1.18B |
| Operating Expenses | 1.38B | 1.51B | 1.73B | 1.63B |
| Depreciation & Amortization | 115M | 129M | 143M | 156M |
| EBITDA | 39M | 59M | 107M | 205M |
| EBITDA Margin | 1.7% | 2.4% | 3.9% | 6.6% |
| Operating Income | (69M) | (69M) | (202M) | 49M |
| Operating Margin | -3.1% | -2.8% | -7.4% | 1.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (7M) | (1M) | (1M) | (236M) |
| Income Before Tax | (76M) | (70M) | (203M) | (187M) |
| Pre-Tax Margin | -3.4% | -2.8% | -7.5% | -6.0% |
| Income Tax Expense | 16M | 38M | 48M | 128M |
| Net Income | (96M) | (112M) | (250M) | (331M) |
| Net Margin | -4.3% | -4.5% | -9.2% | -10.7% |
| EPS (Basic) | (0.34) | (0.40) | (0.89) | (1.29) |
| EPS (Diluted) | (0.34) | (0.40) | (0.89) | (1.29) |
| Weighted Avg Shares | 280.81M | 280.81M | 280.81M | 256.6M |
| Weighted Avg Shares (Diluted) | 280.81M | 280.81M | 280.81M | 256.6M |
MiniMed Group, Inc. Common Stock
NASDAQ:MMED
Intrinsic Alpha fair value
Locked
Current Price
$16.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.